Free Trial

Matt OBrien Analyst Performance

Analyst at Piper Sandler

Matt OBrien is a stock analyst at Piper Sandler in the medical sector, covering 1 publicly traded companies. Over the past year, Matt OBrien has issued 1 stock ratings, including and buy recommendations. While full access to Matt OBrien's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Matt OBrien's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
1 Last 0 Years
Buy Recommendations
100.00% 1 Buy Ratings
Companies Covered
1 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy100.0%1 ratings
Hold0.0%0 ratings
Sell0.0%0 ratings

the majority (100.0%) have been Buy recommendations.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
1 company

Matt OBrien, an analyst at Piper Sandler, currently covers 1 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
1 company
100.0%

Matt OBrien of Piper Sandler specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
HEALTH INFORMATION SERVICES
1 company
100.0%

Matt OBrien's Ratings History at Piper Sandler

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Heartflow, Inc. stock logo
HTFL
Heartflow
9/2/2025Initiated Coverage$31.50$38.00Overweight